Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
Sales | 176 | 40,110 | 161 | 241 | 30,583 |
Gross Profit | 176 | 40,110 | 161 | 241 | 30,583 |
Operating Expenses | 5,867 | 4,986 | 2,958 | 2,935 | 3,198 |
Operating Income | -5,691 | 35,124 | -2,797 | -2,694 | 27,385 |
Other Income | -688 | -3,492 | -426 | -567 | -421 |
Pre-tax Income | -6,379 | 31,632 | -3,223 | -3,261 | 26,964 |
Income Tax | 1 | 688 | 216 | 92 | 195 |
Net Income Continuous | -6,380 | 30,944 | -3,439 | -3,353 | 26,769 |
Net Income | $-6,380 | $30,944 | $-3,439 | $-3,353 | $26,769 |
EPS Basic Total Ops | -0.67 | 2.33 | -0.36 | -0.35 | 1.86 |
EPS Basic Continuous Ops | -0.67 | 3.25 | -0.36 | -0.35 | 2.82 |
EPS Diluted Total Ops | -0.67 | 2.00 | -0.36 | -0.35 | 1.70 |
EPS Diluted Continuous Ops | -0.67 | 2.55 | -0.36 | -0.35 | 2.48 |
EBITDA(a) | $-5,669 | $35,147 | $-2,780 | $-2,679 | $27,396 |